These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20961277)

  • 1. Pulmonary vascular lesions are common in SIV- and SHIV-env-infected macaques.
    George MP; Brower A; Kling H; Shipley T; Kristoff J; Reinhart TA; Murphey-Corb M; Gladwin MT; Champion HC; Morris A; Norris KA
    AIDS Res Hum Retroviruses; 2011 Feb; 27(2):103-11. PubMed ID: 20961277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.
    George MP; Champion HC; Simon M; Guyach S; Tarantelli R; Kling HM; Brower A; Janssen C; Murphy J; Carney JP; Morris A; Gladwin MT; Norris KA
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):374-81. PubMed ID: 23239493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Nef is associated with complex pulmonary vascular lesions in SHIV-nef-infected macaques.
    Marecki JC; Cool CD; Parr JE; Beckey VE; Luciw PA; Tarantal AF; Carville A; Shannon RP; Cota-Gomez A; Tuder RM; Voelkel NF; Flores SC
    Am J Respir Crit Care Med; 2006 Aug; 174(4):437-45. PubMed ID: 16728715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Golgi dysfunction is a common feature in idiopathic human pulmonary hypertension and vascular lesions in SHIV-nef-infected macaques.
    Sehgal PB; Mukhopadhyay S; Patel K; Xu F; Almodóvar S; Tuder RM; Flores SC
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L729-37. PubMed ID: 19648286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
    Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIV/HIV Nef recombinant virus (SHIVnef) produces simian AIDS in rhesus macaques.
    Mandell CP; Reyes RA; Cho K; Sawai ET; Fang AL; Schmidt KA; Luciw PA
    Virology; 1999 Dec; 265(2):235-51. PubMed ID: 10600596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of infectious SIV/HIV-2 chimeras.
    Ranjbar S; Bhattacharya U; Oram J; Stott EJ; Almond N
    AIDS; 2000 Nov; 14(16):2479-84. PubMed ID: 11101058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infected macaques that controlled replication of SIVmac or nonpathogenic SHIV developed sterilizing resistance against pathogenic SHIV(KU-1).
    Stephens EB; Joag SV; Atkinson B; Sahni M; Li Z; Foresman L; Adany I; Narayan O
    Virology; 1997 Aug; 234(2):328-39. PubMed ID: 9268165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).
    Luciw PA; Pratt-Lowe E; Shaw KE; Levy JA; Cheng-Mayer C
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7490-4. PubMed ID: 7638218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques.
    Himathongkham S; Halpin NS; Li J; Stout MW; Miller CJ; Luciw PA
    J Virol; 2000 Sep; 74(17):7851-60. PubMed ID: 10933692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal immunopathogenesis by SIV/HIV-1 (SHIV) containing a variant form of the HIV-1SF33 env gene in juvenile and newborn rhesus macaques.
    Luciw PA; Mandell CP; Himathongkham S; Li J; Low TA; Schmidt KA; Shaw KE; Cheng-Mayer C
    Virology; 1999 Oct; 263(1):112-27. PubMed ID: 10544087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.
    Spikes L; Dalvi P; Tawfik O; Gu H; Voelkel NF; Cheney P; O'Brien-Ladner A; Dhillon NK
    Am J Respir Crit Care Med; 2012 Jun; 185(11):1235-43. PubMed ID: 22447963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    Hsu DC; Sunyakumthorn P; Wegner M; Schuetz A; Silsorn D; Estes JD; Deleage C; Tomusange K; Lakhashe SK; Ruprecht RM; Lombardini E; Im-Erbsin R; Kuncharin Y; Phuang-Ngern Y; Inthawong D; Chuenarom W; Burke R; Robb ML; Ndhlovu LC; Ananworanich J; Valcour V; O'Connell RJ; Spudich S; Michael NL; Vasan S
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
    Miller CJ; McChesney MB; Lü X; Dailey PJ; Chutkowski C; Lu D; Brosio P; Roberts B; Lu Y
    J Virol; 1997 Mar; 71(3):1911-21. PubMed ID: 9032322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAC Mimetic Plus Triple-Combination Bispecific HIVxCD3 Retargeting Molecules in SHIV.C.CH505-Infected, Antiretroviral Therapy-Suppressed Rhesus Macaques.
    Dashti A; Waller C; Mavigner M; Schoof N; Bar KJ; Shaw GM; Vanderford TH; Liang S; Lifson JD; Dunham RM; Ferrari G; Tuyishime M; Lam CK; Nordstrom JL; Margolis DM; Silvestri G; Chahroudi A
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arteriopathy in macaques infected with simian immunodeficiency virus.
    Chalifoux LV; Simon MA; Pauley DR; MacKey JJ; Wyand MS; Ringler DJ
    Lab Invest; 1992 Sep; 67(3):338-49. PubMed ID: 1405492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.